<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-08T11:55:52+08:00</updated>
  <subtitle>世事洞明皆学问，人情练达即文章</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【最新综述】胰腺癌免疫疗法的机遇与挑战</title>
    <updated>2021-01-08T07:54:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/J54NfmLWqdRIsFTK9UFRjA</id>
    <link href="https://mp.weixin.qq.com/s/J54NfmLWqdRIsFTK9UFRjA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>维昇药业TransCon C-型利钠肽II期中国临床试验申请获批</title>
    <updated>2021-01-08T07:54:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/oQIsHk6acYRm0YpPYoufsA</id>
    <link href="https://mp.weixin.qq.com/s/oQIsHk6acYRm0YpPYoufsA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>贝达药业万江：成功的肿瘤药营销重在患者可及，最终塑成品牌、商业双赢</title>
    <updated>2021-01-08T07:54:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/4LHn7t31nMlLBMRrwMq3YQ</id>
    <link href="https://mp.weixin.qq.com/s/4LHn7t31nMlLBMRrwMq3YQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一图读懂 | 2020年乳腺癌指南更新，NCCN vs CSCO对比</title>
    <updated>2021-01-08T07:54:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/StpAxhKz6TYrZoC2X8gPQw</id>
    <link href="https://mp.weixin.qq.com/s/StpAxhKz6TYrZoC2X8gPQw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年创新药获批最大赢家：诺华</title>
    <updated>2021-01-07T08:08:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/hNNIFrWj2Pz__Qrs__1IRA</id>
    <link href="https://mp.weixin.qq.com/s/hNNIFrWj2Pz__Qrs__1IRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>降糖药市场TOP10中国公司产品管线对比</title>
    <updated>2021-01-07T08:08:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/qXEDQO3JDxOcS5xCYX4XiQ</id>
    <link href="https://mp.weixin.qq.com/s/qXEDQO3JDxOcS5xCYX4XiQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田副总裁陈杰博士：洞见悬而未决的中国特色临床痛点</title>
    <updated>2021-01-07T08:08:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/BaXPsXsDvFj-iMO09AAsjA</id>
    <link href="https://mp.weixin.qq.com/s/BaXPsXsDvFj-iMO09AAsjA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>注册管理丨给热爱以岁月，给努力以路径</title>
    <updated>2021-01-07T08:08:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/Xa-H6IOr2qtVMgtRaMa7qQ</id>
    <link href="https://mp.weixin.qq.com/s/Xa-H6IOr2qtVMgtRaMa7qQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>礼来乳腺癌新药唯择®（阿贝西利片）在华获批！</title>
    <updated>2021-01-06T08:11:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/yw5aa6xHxVXHu-MFJ0rtFQ</id>
    <link href="https://mp.weixin.qq.com/s/yw5aa6xHxVXHu-MFJ0rtFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>艾棣维欣向INOVIO提供DNA疫苗生产技术许可，共同推进新冠疫苗II/III期临床及商业化</title>
    <updated>2021-01-06T08:11:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/gFujT-ObDZ2vNwaITCL2kw</id>
    <link href="https://mp.weixin.qq.com/s/gFujT-ObDZ2vNwaITCL2kw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专注高技术壁垒复杂制剂！燃点医药获得数千万元天使轮融资</title>
    <updated>2021-01-06T08:11:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/eilGOZiFDKaVOQOlke3Gmw</id>
    <link href="https://mp.weixin.qq.com/s/eilGOZiFDKaVOQOlke3Gmw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>维健医药与Immedica签署协议，维健医药获得Ravicti®在中国和其他若干亚太国家的独家商业化权益</title>
    <updated>2021-01-06T08:11:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/AHwHEIUOQux7J4qbXsgKUw</id>
    <link href="https://mp.weixin.qq.com/s/AHwHEIUOQux7J4qbXsgKUw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首个国内研发的新一代NTRK/ROS1多激酶抑制剂项目完成I期临床首例受试者给药</title>
    <updated>2021-01-06T08:11:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/yPyPP0V1w7jXnplD99Tx8Q</id>
    <link href="https://mp.weixin.qq.com/s/yPyPP0V1w7jXnplD99Tx8Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国first in class新药研发，还缺什么？</title>
    <updated>2021-01-05T08:02:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/c-daa2n3vGJa18rt8yIE_w</id>
    <link href="https://mp.weixin.qq.com/s/c-daa2n3vGJa18rt8yIE_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>礼来中国副总裁钱江：以学术为导向，深入挖掘市场尚未被满足的临床需求</title>
    <updated>2021-01-05T08:02:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/YXTvVh16-K2-fTn2F9Yu4w</id>
    <link href="https://mp.weixin.qq.com/s/YXTvVh16-K2-fTn2F9Yu4w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亚盛医药囊获第9项FDA孤儿药资格认定，创中国药企之最</title>
    <updated>2021-01-05T08:02:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/phvR6c8dWpfLkw6q91r2og</id>
    <link href="https://mp.weixin.qq.com/s/phvR6c8dWpfLkw6q91r2og" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>安进KRAS抑制剂sotorasib的专利保护策略</title>
    <updated>2021-01-04T07:47:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/pq92yYetn9vl7RyvJ9ZKnQ</id>
    <link href="https://mp.weixin.qq.com/s/pq92yYetn9vl7RyvJ9ZKnQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一图读懂 | 2020年NCCN肺癌指南历版更新要点</title>
    <updated>2021-01-04T07:47:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/ceBMky86ztMov-s6VCVQug</id>
    <link href="https://mp.weixin.qq.com/s/ceBMky86ztMov-s6VCVQug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>德琪医药在韩国提交Selinexor新药上市申请，用于治疗复发难治性多发性骨髓瘤及弥漫性大B细胞淋巴瘤</title>
    <updated>2021-01-04T07:47:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/XQZCY85jhKjpZ7FxI5jdcg</id>
    <link href="https://mp.weixin.qq.com/s/XQZCY85jhKjpZ7FxI5jdcg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年中国创新药license in/out交易TOP15</title>
    <updated>2021-01-03T11:03:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/1fJKEh1hPsswbu8GaXfvWA</id>
    <link href="https://mp.weixin.qq.com/s/1fJKEh1hPsswbu8GaXfvWA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>